|
Without a flushing tube correctly after administering EN.
|
0.858
|
0.254
|
0.128
|
0.687
|
|
Without confirming gastric retention before administering EN.
|
0.833
|
0.248
|
0.236
|
0.677
|
|
Without confirming the location of the tube before administering EN.
|
0.817
|
0.219
|
0.162
|
0.635
|
|
The pump speed of EN solution was not personalized.
|
0.811
|
0.221
|
0.274
|
0.716
|
|
Without elevating bed head at least 30° during EN
|
0.796
|
0.205
|
0.124
|
0.653
|
|
Insufficient tube placement.
|
0.781
|
0.328
|
0.189
|
0.701
|
|
The complications of EN were not dealt with timely.
|
0.778
|
0.233
|
0.299
|
0.693
|
|
The person who placed the tube was not realized that the tube was misplaced.
|
0.771
|
0.288
|
0.201
|
0.682
|
|
The tube was lack of identification.
|
0.767
|
0.305
|
0.124
|
0.671
|
|
Without using a pump to administer EN.
|
0.766
|
0.147
|
0.165
|
0.578
|
|
The tube was misconnected.
|
0.739
|
0.294
|
0.063
|
0.616
|
|
The medical staff was lack of knowledge of EN.
|
0.733
|
0.294
|
0.288
|
0.684
|
|
The temperature of EN solution was inappropriate.
|
0.718
|
0.383
|
0.038
|
0.675
|
|
Medical staff did not update the knowledge of EN timely.
|
0.713
|
0.312
|
0.368
|
0.703
|
|
Screening and evaluation were not performed as required during EN administering.
|
0.710
|
0.412
|
0.064
|
0.683
|
|
Constipation may occur during EN administering.
|
0.222
|
0.831
|
−0.054
|
0.585
|
|
Metabolic complications may occur during EN administering.
|
0.285
|
0.817
|
0.060
|
0.567
|
|
Abdominal distension may occur during EN administering.
|
0.234
|
0.799
|
0.048
|
0.528
|
|
Abdominal cramps may occur during EN administration.
|
0.291
|
0.794
|
0.098
|
0.591
|
|
Diarrhea may occur during EN administering.
|
0.167
|
0.778
|
0.100
|
0.508
|
|
Long-term compression of the tube causes local skin/mucosal damage.
|
0.203
|
0.773
|
0.132
|
0.549
|
|
Infection may occur during EN administering.
|
0.341
|
0.728
|
0.100
|
0.608
|
|
Aspiration may occur during EN administering.
|
0.247
|
0.673
|
0.673
|
0.550
|
|
Long-term use of enteral tube feeding can lead to degeneration of gastric function.
|
0.271
|
0.709
|
0.101
|
0.585
|
|
Tube occlusion may occur during EN administering.
|
0.144
|
0.748
|
0.153
|
0.481
|
|
Tube displacement may occur during EN administering.
|
0.353
|
0.736
|
0.074
|
0.563
|
|
The total energy intake of EN was not up to patients’ demand.
|
0.278
|
0.080
|
0.891
|
0.485
|
|
Without choosing the appropriate EN solution based on the changes in disease.
|
0.324
|
0.090
|
0.876
|
0.520
|
|
The intake of EN solution was excessive.
|
0.323
|
0.081
|
0.876
|
0.522
|
|
Eigenvalue
|
15.238
|
3.688
|
1.768
| |
|
Explained variance rate (%)
|
52.544
|
12.716
|
6.096
| |
